Skip to main content

Table 3 OA medication prescriptions from OA visits and all visits

From: The burden of hip and knee osteoarthritis in Finnish occupational healthcare

ATC code

Medication

OA visits

All visits

 

Hip OA

Knee OA

Hip/Knee OA

Hip OA

Knee OA

Hip/Knee OA

Controls

p-value

fold change

n

%

n

%

n

%

n

%

n

%

n

%

n

%

M01AH05

etoricoxib

1450

22.6%

6215

21.7%

7665

21.8%

3352

52.2%

15,166

52.9%

18,518

52.7%

6118

17.4%

< 0.001

3.0

M01AE01

ibuprofen

815

12.7%

3741

13.0%

4556

13.0%

3264

50.9%

15,172

52.9%

18,436

52.5%

9741

27.8%

< 0.001

1.9

N02BE01

paracetamol

1228

19.1%

4396

15.3%

5624

16.0%

3233

50.4%

13,749

47.9%

16,982

48.4%

6644

18.9%

< 0.001

2.6

M01AB05

diclofenac

420

6.6%

1671

5.8%

2091

6.0%

1845

28.8%

8152

28.4%

9997

28.5%

4201

12.0%

< 0.001

2.4

M03BX02

tizanidine

190

3.0%

452

1.6%

642

1.8%

1841

28.7%

7846

27.3%

9687

27.6%

5070

14.4%

< 0.001

1.9

M01AX25

chondroitin sulfate

723

11.3%

4137

14.4%

4860

13.8%

1252

19.5%

6841

23.8%

8093

23.1%

352

1.0%

< 0.001

23.0

N02AJ06

codeine & paracetamol

434

6.8%

1255

4.4%

1689

4.8%

1363

21.2%

5498

19.2%

6861

19.5%

2631

7.5%

< 0.001

2.6

M01AE02

naproxen

240

3.7%

987

3.4%

1227

3.5%

1128

17.6%

5297

18.5%

6425

18.3%

2789

8.0%

< 0.001

2.3

N02AA59

codeine, combinations

279

4.4%

819

2.9%

1098

3.1%

1155

18.0%

4835

16.9%

5990

17.1%

2017

5.8%

< 0.001

3.0

M01AX05

glucosamine

447

7.0%

2488

8.7%

2935

8.4%

895

14.0%

4884

17.0%

5779

16.5%

374

1.1%

< 0.001

15.5

M02AA15

diclofenac, topical

112

1.8%

815

2.8%

927

2.6%

801

12.5%

4269

14.9%

5070

14.4%

1624

4.6%

< 0.001

3.1

M01AC06

meloxicam

196

3.1%

1001

3.5%

1197

3.4%

796

12.4%

3662

12.8%

4458

12.7%

1206

3.4%

< 0.001

3.7

M01AE52

naproxen & esomeprazole

234

3.7%

809

2.8%

1043

3.0%

673

10.5%

2955

10.3%

3628

10.3%

1021

2.9%

< 0.001

3.6

N02AX02

tramadol

279

4.4%

669

2.3%

948

2.7%

762

11.9%

2803

9.8%

3565

10.2%

1043

3.0%

< 0.001

3.4

N06AA09

amitriptyline

97

1.5%

305

1.1%

402

1.2%

581

9.1%

2148

7.5%

2729

7.8%

1019

2.9%

< 0.001

2.7

M02AA07

piroxicam

32

0.5%

270

0.9%

302

0.9%

344

5.4%

1880

6.6%

2224

6.3%

733

2.1%

< 0.001

3.0

N03AX16

pregabalin

62

1.0%

171

0.6%

233

0.7%

336

5.2%

1203

4.2%

1539

4.4%

573

1.6%

< 0.001

2.7

M01AH01

celecoxib

90

1.4%

241

0.8%

331

0.9%

237

3.7%

860

3.0%

1097

3.1%

236

0.7%

< 0.001

4.6

N03AX12

gabapentin

49

0.9%

137

0.5%

186

0.5%

259

4.0%

791

2.8%

1050

3.0%

349

1.0%

< 0.001

3.0

M09AX01

hyaluronic acid, intra-articular

29

0.5%

648

2.3%

677

1.9%

53

0.8%

980

3.4%

1033

2.9%

12

0.0%

< 0.001

86.1

  1. Data is organized based on prevalence in the hip/knee OA patients from all visits. P-values and fold changes were calculated between all OA patients from all visits and all controls. The p-values were calculated using the Chi-squared test